Daewon Pharmaceutical Co., Ltd.
Clinical trials sponsored by Daewon Pharmaceutical Co., Ltd., explained in plain language.
-
New allergy pill aims to clear stuffy noses in asthma patients
Symptom relief Recruiting nowThis study tests two versions of an experimental allergy drug, DW1807 and DW1807-R2, in 274 adults who have year-round allergic rhinitis (hay fever) and asthma. Participants take one pill daily for 4 weeks. The main goal is to see which version better reduces nasal symptoms like …
Phase: PHASE3 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 23, 2026 11:59 UTC
-
New drug DW4421 put through safety check with NSAIDs in healthy volunteers
Knowledge-focused Recruiting nowThis early-stage trial is testing an experimental drug called DW4421 alongside three different NSAID painkillers in 150 healthy adults aged 19 to 50. The goal is to see how the drugs interact and whether the combination is safe. Participants will take DW4421 alone or with one of …
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:58 UTC